Phi Therapeutics
San Francisco, US
Biotech
Founders & leadership
MS
Maria S. ChoExecutive Officer, Director
YV
Yug VarmaExecutive Officer, Director
JS
Jun S. LiDirector
Reported raises · per SEC filings
Form D private placements$7.7MraisedJun 2024 · 22 investors · Biotechnology
Rule 506(b)$660KraisedJan 2022 · 7 investors · Biotechnology
Rule 506(b)$575KraisedJun 2019 · 4 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.